| Application no. and date | 17787774.3 (espacenet) (Federated) (European Patent Register), 20171005 | | Patent/reg. no. and date | DK/EP 3523283, 20210609 | | Publication date | 20190814 | | Priority no. and date | US 201662404474 P, 20161005 | | EP pub. no. and date |
EP 3523283 20190814 | | Effective date | | | Applicant/owner | Mitobridge, Inc., 1030 Massachusetts Avenue
Suite 200
Cambridge, MA 02138, US | | Applicant ref. no. | MCCQ/P68680EP | | Inventor | TRZASKA, Scott, 8 Renzi Road
Raritan, NJ 08869, US,
LAGU, Bharat, 21 Lexington Drive
Acton, MA 01720, US | | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 1550 København V, DK | | Opponent | | | IPC Class | A61K 31/4174 (2006.01) , A61K 31/4439 (2006.01) , A61P 35/00 (2006.01) , C07D 233/64 (2006.01) , C07D 401/04 (2006.01) | | Title | CRYSTALLINE AND SALT FORMS OF PPAR AGONIST COMPOUNDS | | Int. application no. | US2017055403 | | Int. publication no. | WO2018067860 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
